La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Serotonin »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Serotonergic Neurons < Serotonin < Serotonin 5-HT2 Receptor Agonists  Facettes :

List of bibliographic references indexed by Serotonin

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000C38 (2013) Philippe Huot [Canada] ; Susan H. FoxThe serotonergic system in motor and non-motor manifestations of Parkinson's disease.
000E37 (2013) Golnasim Riahi ; Marc Morissette ; Pershia Samadi ; Martin Parent ; Thérèse Di PaoloBasal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia.
001574 (2011) Philippe Huot [Canada] ; Susan H. Fox ; Jonathan M. BrotchieThe serotonergic system in Parkinson's disease.
001680 (2011) Julia Sacher [Canada, Allemagne] ; Eugenii A. Rabiner [Canada] ; Michael Clark [Canada] ; Pablo Rusjan [Canada] ; Alexandra Soliman [Canada] ; Rada Boskovic [Canada] ; Stephen J. Kish [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Jeffrey H. Meyer [Canada]Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [11C]-harmine positron emission tomography study
001993 (2010) Benedicte Ballanger [Canada] ; Antonio P. Strafella ; Thilo Van Eimeren ; Mateusz Zurowski ; Pablo M. Rusjan ; Sylvain Houle ; Susan H. FoxSerotonin 2A receptors and visual hallucinations in Parkinson disease.
001A94 (2010) Emmanuelle Pourcher [Canada] ; Sophie Rémillard ; Henri CohenAffect in Parkinson's disease: validation of the two-factor approach.
001F59 (2009) Susan H. Fox [Canada] ; Rosalind Chuang [Canada] ; Jonathan M. Brotchie [Canada]Serotonin and Parkinson's disease: On movement, mood, and madness
002158 (2008) Susan H. Fox [Canada] ; Rosalind Chuang ; Jonathan M. BrotchieParkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy.
002238 (2008) Stephen J. Kish [Canada, Niger] ; Junchao Tong [Canada] ; Oleh Hornykiewicz [Canada] ; Ali Rajput [Canada] ; Li-Jan Chang [Canada] ; Mark Guttman [Canada] ; Yoshiaki Furukawa [Canada]Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease
002606 (2007) M. Guttman [Canada] ; I. Boileau [Canada] ; J. Warsh [Canada] ; J. A. Saint-Cyr [Canada] ; N. Ginovart [Canada] ; T. Mccluskey [Canada] ; S. Houle [Canada] ; A. Wilson [Canada] ; E. Mundo [Italie] ; P. Rusjan [Canada] ; J. Meyer [Canada] ; S. J. Kish [Canada]Brain serotonin transporter binding in non‐depressed patients with Parkinson's disease
002F50 (2003) Stephen J. Kish [Canada]Biochemistry of Parkinson's disease: Is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?
003826 (1999) T. A. Reader [Canada] ; K. M. Dewar [Canada]Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum : implications for human Parkinson's disease
004232 (1994) K. Shannak ; A. Rajput [Canada] ; B. Rozdilsky [Canada] ; S. Kish ; J. Gilbert [Canada] ; O. HornykiewiczNoradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects
004599 (1992) B. Lach [Canada] ; D. Grimes [Canada] ; B. Benoit [Canada] ; A. Minkiewicz-Janda [Canada]Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material
004857 (1990) A E Taylor [Canada] ; J A Saint-CyrDepression in Parkinson's disease: reconciling physiological and psychological perspectives.
004993 (1990) M. Guttman ; H. C. Fibiger ; A. Jakubovic ; D. B. CalneIntracarotid 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration: biochemical and behavioral observations in a primate model of hemiparkinsonism
004A01 (1990) T. L. Perry ; J. M. Wright ; K. Berry ; S. Hansen ; T. L. Jr PerryDominantly inherited apathy, central hypoventilation, and Parkinson's syndrome : clinical, biochemical, and neuropathologic studies of 2 new cases
004D01 (1987) R. S. Hannah [Canada] ; D. Parkinson [Canada] ; A. W. Spira [Canada] ; S. H. Roth [Canada]The effect of chlorpromazine on monoamine levels in the rat cerebellum and hippocampus: a developmental study

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Serotonin" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Serotonin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Serotonin
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022